HSA-free formulations of interferon-beta

Stabilized pharmaceutical compositions comprising substantially monomeric interferon-beta (1FN-²) and methods useful in their preparation are provided. The compositions comprise the IFN-² solubilised in a low-ionic-strength formulation that maintains the composition at a pH of about 5.0. Methods for...

Full description

Saved in:
Bibliographic Details
Main Authors SHIRLEY, BRET, BABUKA, SUSAN, TELLERS, MELANIE, CHOE, MINNA
Format Patent
LanguageEnglish
French
German
Published 16.02.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Stabilized pharmaceutical compositions comprising substantially monomeric interferon-beta (1FN-²) and methods useful in their preparation are provided. The compositions comprise the IFN-² solubilised in a low-ionic-strength formulation that maintains the composition at a pH of about 5.0. Methods for preparing these compositions, and for increasing solubility of IFN-² in pharmaceutical compositions, are provided.
AbstractList Stabilized pharmaceutical compositions comprising substantially monomeric interferon-beta (1FN-²) and methods useful in their preparation are provided. The compositions comprise the IFN-² solubilised in a low-ionic-strength formulation that maintains the composition at a pH of about 5.0. Methods for preparing these compositions, and for increasing solubility of IFN-² in pharmaceutical compositions, are provided.
Author TELLERS, MELANIE
SHIRLEY, BRET
CHOE, MINNA
BABUKA, SUSAN
Author_xml – fullname: SHIRLEY, BRET
– fullname: BABUKA, SUSAN
– fullname: TELLERS, MELANIE
– fullname: CHOE, MINNA
BookMark eNrjYmDJy89L5WTQ8Ah21E0rSk1VSMsvyi3NSSzJzM8rVshPU8jMK0ktSkstys_TTUotSeRhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAUZGFsYWlmaORsZEKAEATmEpiw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate HSA-frei Interferon-beta Formulierungen
Formulation d'interférone beta ne contenant pas de HSA
ExternalDocumentID EP2283896A2
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2283896A23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:59:15 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2283896A23
Notes Application Number: EP20100180630
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110216&DB=EPODOC&CC=EP&NR=2283896A2
ParticipantIDs epo_espacenet_EP2283896A2
PublicationCentury 2000
PublicationDate 20110216
PublicationDateYYYYMMDD 2011-02-16
PublicationDate_xml – month: 02
  year: 2011
  text: 20110216
  day: 16
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies NOVARTIS VACCINES AND DIAGNOSTICS, INC
RelatedCompanies_xml – name: NOVARTIS VACCINES AND DIAGNOSTICS, INC
Score 2.798582
Snippet Stabilized pharmaceutical compositions comprising substantially monomeric interferon-beta (1FN-²) and methods useful in their preparation are provided. The...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title HSA-free formulations of interferon-beta
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110216&DB=EPODOC&locale=&CC=EP&NR=2283896A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-L8ogcpXoJk6dLuUGTrB0XYVnTKbmNJU9ilHW2H_74vtZ1e9BYSeHkJ_N5X8t4DeGCOkLbD18ThVBBL0YQIyShJOHcklQnKQ-0oTmc8erdelsNlBzZtLkxdJ_SzLo6IiJKI96qW19ufIJZf_60sn8QGp_LncOH6ZtKG-1BlcdOfuEE89-ee6Xk4Mmevrq7y4oz4GKX1AVrRtgZD8DHRSSnb3xolPIXDGIll1Rl0VNaDY69tvNaDo2nz3o3DBnrlOTxGb2OSFkoZ2sxsmm6VRp4auuJDkaoiz4hApi_ACIOFFxHccrU_3iqI98yxS-ii16-uwKBCrcWQKyF0siezBBsJWzKFLscgkdzqQ_9PMtf_rN3AyXdYdEAov4VuVezUHerVStzXN_IFDf18Wg
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgRg3GCA2Xj2gikuEsnZpd5jQ1ocK7CUYaLdpTlNpl27qivj7OGUdXOAWJZLjRPr8SmwD3FouSscVC-YKjsxWPGYoLc5iIVzJZUzyUDuKw5GI3uynWXtWgWWZC1PUCf0siiMSoiThPS_k9foniOUXfys397ikqdVDOO36ZlyG-0hlCdPvd4PJ2B97pufRyBy9dHWVF7cjeiSt98jCdjQYgve-TkpZ_9Yo4RHsT4hYmh9DRaV1qHll47U6HAy379003EJvcwJ30WuPJZlShjYzt023NsYqMXTFhyxR2SplSEyfghEGUy9itOV8d7x5MNkxZ51Blbx-dQ4GR7XAtlCIOtnTstHqoCMtRS5HK5bCbkDjTzLNf9ZuoBZNh4P54HH0fAGH3yHSFuPiEqp59qGuSMfmeF3czhcN439N
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HSA-free+formulations+of+interferon-beta&rft.inventor=SHIRLEY%2C+BRET&rft.inventor=BABUKA%2C+SUSAN&rft.inventor=TELLERS%2C+MELANIE&rft.inventor=CHOE%2C+MINNA&rft.date=2011-02-16&rft.externalDBID=A2&rft.externalDocID=EP2283896A2